These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 11513444)

  • 1. Defibrillation efficacy comparing a subcutaneous array electrode versus an "active can" implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an "active can" implantable cardioverter defibrillator: results from active can versus array trials I and II.
    Gradaus R; Block M; Seidl K; Brunn J; Isgro F; Hammel D; Hauer B; Breithardt G; Bocker D
    J Cardiovasc Electrophysiol; 2001 Aug; 12(8):921-7. PubMed ID: 11513444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
    Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
    Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system.
    Rashba EJ; Shorofsky SR; Brown T; Peters RW; Gold MR
    Heart Rhythm; 2005 Jan; 2(1):49-54. PubMed ID: 15851265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of benefit of an active pectoral pulse generator on atrial defibrillation thresholds.
    Gold MR; Shorofsky SR; Bouhouch R; Joy RA; Kirby DS; Osman AF; Rashba EJ
    J Cardiovasc Electrophysiol; 2002 Apr; 13(4):332-5. PubMed ID: 12033348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized comparison in humans of biphasic waveform 60-microF and 120-microF capacitance pulses using a unipolar defibrillation system.
    Bardy GH; Poole JE; Kudenchuk PJ; Dolack GL; Mehra R; DeGroot P; Raitt MH; Jones GK; Johnson G
    Circulation; 1995 Jan; 91(1):91-5. PubMed ID: 7805224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal method to achieve consistently low defibrillation energy requirements.
    Winter J; Zimmermann N; Lidolt H; Dees H; Perings C; Vester EG; Poll L; Schipke JD; Contzen K; Gams E
    Am J Cardiol; 2000 Nov; 86(9A):71K-75K. PubMed ID: 11084103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead?
    Osswald BR; De Simone R; Most S; Tochtermann U; Tanzeem A; Karck M
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):489-92. PubMed ID: 19144533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomized evaluation of implantable cardioverter-defibrillator size on unipolar defibrillation system efficacy.
    Jones GK; Poole JE; Kudenchuk PJ; Dolack GL; Johnson G; DeGroot P; Gleva MJ; Raitt M; Bardy GH
    Circulation; 1995 Nov; 92(10):2940-3. PubMed ID: 7586263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internal defibrillation with smaller capacitors: a prospective randomized cross-over comparison of defibrillation efficacy obtained with 90-microF and 125-microF capacitors in humans.
    Block M; Hammel D; Böcker D; Borggrefe M; Seifert T; Fastenrath C; Scheld HH; Breithardt G
    J Cardiovasc Electrophysiol; 1995 May; 6(5):333-42. PubMed ID: 7551301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defibrillation thresholds with right pectoral implantable cardioverter defibrillators and impact of waveform tuning (the Tilt and Tune trial).
    Varma N; Schaerf R; Kalbfleisch S; Pimentel R; Kroll MW; Oza A
    Europace; 2017 Nov; 19(11):1810-1817. PubMed ID: 27986795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized evaluation of a nonthoracotomy implantable cardioverter defibrillator lead system. Endotak/PRX Investigator Group.
    Baker JH; Epstein AE; Voshage-Stahl L
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):72-8. PubMed ID: 9121974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leakage of energy to the body surface during defibrillation shock by an implantable cardioverter-defibrillator (ICD) system--experimental evaluation during defibrillation shocks through the right ventricular lead and the subcutaneous active-can in canines.
    Niwano S; Kitano Y; Moriguchi M; Yoshizawa N; Kashiwa T; Suyama M; Toyoshima T; Izumi T
    Jpn Circ J; 2001 Mar; 65(3):219-25. PubMed ID: 11266198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Submuscular versus subcutaneous pectoral implantation of cardioverter-defibrillators: effect on high voltage pathway impedance and defibrillation efficacy.
    Iskos D; Lock K; Lurie KG; Fahy GJ; Petersen-Stejskal S; Benditt DG
    J Interv Card Electrophysiol; 1998 Mar; 2(1):47-52. PubMed ID: 9869996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The subcutaneous array: a new lead adjunct for the transvenous ICD to lower defibrillation thresholds.
    Higgins SL; Alexander DC; Kuypers CJ; Brewster SA
    Pacing Clin Electrophysiol; 1995 Aug; 18(8):1540-8. PubMed ID: 7479175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a single element subcutaneous array electrode added to a transvenous electrode configuration on the defibrillation field and the defibrillation threshold.
    Kühlkamp V; Dörnberger V; Khalighi K; Mewis C; Suchalla R; Ziemer G; Seipel L
    Pacing Clin Electrophysiol; 1998 Dec; 21(12):2596-605. PubMed ID: 9894650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of epicardial patches on defibrillation threshold with nonthoracotomy lead configurations.
    Fotuhi PC; Ideker RE; Idriss SF; Callihan RL; Walker RG; Alt EU
    Circulation; 1995 Nov; 92(10):3082-8. PubMed ID: 7586279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reproducibility of the effectiveness of defibrillation for terminating induced ventricular fibrillation using intraoperatively measured defibrillation threshold energy in patients with implanted cardioverter-defibrillator].
    Jung J; Neuzner J; Himmrich E; Vester E; Michel U; Fries R; Pitschner H; Liebrich A; Ganschow U; Heisel A
    Z Kardiol; 1998 Dec; 87(12):971-7. PubMed ID: 10025070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized prospective study of single coil versus dual coil defibrillation in patients with ventricular arrhythmias undergoing implantable cardioverter defibrillator therapy.
    Rinaldi CA; Simon RD; Geelen P; Reek S; Baszko A; Kuehl M; Gill JS
    Pacing Clin Electrophysiol; 2003 Aug; 26(8):1684-90. PubMed ID: 12877701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.